EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
107 hedge funds and large institutions have $163M invested in Eagle Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 48 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
-19
Holders Change %
-15.08%
% of All Funds
1.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
12
Increased
31
Reduced
48
Closed
31
Calls
$22K
Puts
$21K
Net Calls
+$1K
Net Calls Change
-$45K
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
$14M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
$4.43M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$4.61M |
| 4 |
E
Ergoteles
New York
|
$0 |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
$4.46M |
